The Vector core will produce herpes simplex virus (HSV)-based amplicon vectors, adenoviral vectors, and retroviral vectors. These will be used in Project 1 in mixed neuronal/glial cultures and pure astrocyte cultures, as well as in Project 2, for in vivo ischemia studies. HSV and adenoviral vectors will be generated expressing the genes for CuZn- superoxide dismutase (SOD1), glutathione peroxidase (the prior two either individually, or in combination, Bcl-2, and Hsp70. All of the HSV and adenoviral vectors will be """"""""bicistronic"""""""", expressing both the gene in question, as well as a reporter gene. For each experimental vector, the cognate control vector will contain the same gene in question with a stop codon inserted in its center, insuring non-expression. Similar controls will be generated for the adenoviral vectors. Retroviral vectors to express SOD1, Mn-SOD (SOD2), Bcl-2 and Hsp70 will be produced. Control vector will express either the reporter gene beta-galactosidase or a stop codon version of the gene of interest. The retroviral vectors for HSP70 and Bcl-2 have been constructed and they will be produced in the vector core. In addition new vectors to express SOD1 and SOD2 (separately) will be constructed and then produced. The purpose of the Vector Core will be to ensure a constant supply of vectors for the various groups, to insure quality control in the production of such vectors, and to troubleshoot problems, as they arise, in individual laboratories in the use of vectors.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Knowland, Daniel; Arac, Ahmet; Sekiguchi, Kohei J et al. (2014) Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82:603-17
Arac, Ahmet; Grimbaldeston, Michele A; Nepomuceno, Andrew R B et al. (2014) Evidence that meningeal mast cells can worsen stroke pathology in mice. Am J Pathol 184:2493-504
Daadi, Marcel M; Hu, Shijun; Klausner, Jill et al. (2013) Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant 22:881-92
Cheng, Michelle Y; Lee, Alex G; Culbertson, Collin et al. (2012) Prokineticin 2 is an endangering mediator of cerebral ischemic injury. Proc Natl Acad Sci U S A 109:5475-80
Horie, Nobutaka; Pereira, Marta P; Niizuma, Kuniyasu et al. (2011) Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29:274-85
Andres, Robert H; Horie, Nobutaka; Slikker, William et al. (2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134:1777-89
Andres, Robert H; Choi, Raymond; Pendharkar, Arjun V et al. (2011) The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42:2923-31
Cheng, Michelle Y; Lee, I-Ping; Jin, Michael et al. (2011) An insult-inducible vector system activated by hypoxia and oxidative stress for neuronal gene therapy. Transl Stroke Res 2:92-100
Arac, Ahmet; Brownell, Sara E; Rothbard, Jonathan B et al. (2011) Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A 108:13287-92
Encarnacion, Angelo; Horie, Nobutaka; Keren-Gill, Hadar et al. (2011) Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods 196:247-57

Showing the most recent 10 out of 117 publications